Status:
COMPLETED
Use of a Bearable Continuous Interstitial Glucose Monitoring Device (GuardianR) During Teaching Sessions to Functional Insulin Therapy Concept in Patients Suffering From Type 1 Diabetes: Evaluation at 6 and 12 Months
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Diabetes Complications
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The objective of the project is to evaluate advantages from the use of a bearable continuous interstitial glucose monitoring device (GuardianR) during educative sessions of diabetic patients dedicated...
Detailed Description
Two groups of 60 patients (experimental and control groups) will be followed and evaluated at 6 and 12 months. We do think that this new tool would facilitate education of patients and lead further to...
Eligibility Criteria
Inclusion
- Subject major, from 18 to 70 years old
- Diabetes of type 1 defined according to the criteria of American Diabetes Association
- Insulinic treatment for at least 12 months
- Understood HbA1C enters 6,5 and 9,5 %
Exclusion
- Minor subjects or under guardianship
- Unbalance kétosis current or recent
- Pregnancy
- Incapacitated to participate weekly complete educational in the functional insulin-therapy,
- Evolutionary severe general disease
- Psychiatric confusions
- Unbalance chronic (HbA1c \> 9,5 %) connected to an absence of adapted coverage or to abnormal behaviors
- Pathology making not interpretable the rate of HbA1c (hemoglobinopathy, anemia)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00682903
Start Date
January 1 2008
End Date
February 1 2011
Last Update
August 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU timone
Marseille, Bouches du Rhone, France, 13005